InsidersTradesSigma
Explore the full record of transactions filed by Per Wold-Olsen, Président du Conseil. Director active across 6 companies, notably Senzime AB. Cumulatively, 4 filings have been published. Activity tracked since 22 April 2025. The latest transaction was disclosed on 17 March 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Per Wold-Olsen is the chairman of the board of Senzime AB. He oversees the board's activities and plays a key role in the strategic direction of the company. Senzime AB specializes in developing medical solutions. Per Wold-Olsen contributes to corporate governance and strategic decision-making, ensuring the success and growth of the organization.